Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H13N3O3 |
Molecular Weight | 259.2606 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)NC1=NC2=C(N1)C=CC(=C2)C(=O)C3CC3
InChI
InChIKey=OXLKOMYHDYVIDM-UHFFFAOYSA-N
InChI=1S/C13H13N3O3/c1-19-13(18)16-12-14-9-5-4-8(6-10(9)15-12)11(17)7-2-3-7/h4-7H,2-3H2,1H3,(H2,14,15,16,18)
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Comparative trial on the therapeutic effectiveness of the new anthelmintic drug: ciclobendazole. | 1978 Dec |
|
In vitro susceptibilities of the AIDS-associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolite, and 12 additional benzimidazole derivatives. | 1997 Dec |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/493246
Oxyuriasis treatment: 50 children were treated twice with 100 mg of cyclobendazole each, at a weekly interval
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7811023
Cyclobendazole inhibited G. lamblia growth with IC50 0.047 ug/ml.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C250
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
||
|
WHO-ATC |
P02CA04
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
31431-43-3
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | |||
|
CICLOBENDAZOLE
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | |||
|
DB13465
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | |||
|
335307
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | |||
|
JF3KQ40J31
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | |||
|
m3975
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID9057713
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | |||
|
3120
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | |||
|
SUB06240MIG
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | |||
|
250-637-5
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | |||
|
35803
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | |||
|
100000081906
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | |||
|
C78041
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | |||
|
3570
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | |||
|
CHEMBL1788401
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY | |||
|
C014415
Created by
admin on Fri Dec 15 16:18:13 GMT 2023 , Edited by admin on Fri Dec 15 16:18:13 GMT 2023
|
PRIMARY |
ACTIVE MOIETY